Safety and incidence of COVID-19 following ChAdOx1(AZD1222) COVID-19 vaccination in Botswana - 17/05/23
Doi : 10.1016/j.jinf.2023.02.037
⁎Correspondence to: Botswana Harvard AIDS Institute Partnership, Private Bag BO320, Gaborone, Botswana.Botswana Harvard AIDS Institute PartnershipPrivate Bag BO320GaboroneBotswana
Alane Izu 
South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
Department of Science and Innovation/National Research Foundation South African Research Chair Initiative in Vaccine Preventable Diseases Unit, University of the Witwatersrand, Johannesburg, South Africa
Tendani Gaolathe
Harvard T.H. Chan School of Public Health, Department of Immunology and Infectious Diseases, Boston, United States
University of Botswana, Gaborone, Botswana
Adam Walker
Medical Evidence, Vaccine and Immune Therapies, BioPharmaceuticals Medicine, AstraZeneca, Cambridge, UK
Lucy Carty
Medical and Payer Evidence Statistics, BioPharmaceuticals Medicine, AstraZeneca, Cambridge, UK
Panayiotis Georgiou
Late Development, Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK
Coulson Kgathi , Tumalano Sekoto , Ngozana Seonyatseng , Tuelo Mogashoa , Comfort Maphorisa , Terence Mohammed , Tshenolo Ntalabgwe , Tshepho T. Frank , Boitumelo Matlhaku , Ame Diphoko , Thandie Phindela , Agripa Kaunda , Poloko Kgari , Thomas Kanyakula , Gape Palalani , Isabella Phakedi
, Tumalano Sekoto , Ngozana Seonyatseng , Tuelo Mogashoa , Comfort Maphorisa , Terence Mohammed , Tshenolo Ntalabgwe , Tshepho T. Frank , Boitumelo Matlhaku , Ame Diphoko , Thandie Phindela , Agripa Kaunda , Poloko Kgari , Thomas Kanyakula , Gape Palalani , Isabella Phakedi (Botswana AZD1222 study team)
Botswana Harvard AIDS Institute Partnership, Botswana
Sylvia Taylor
Infection Evidence Strategy, Vaccine and Immune Therapies, BioPharmaceuticals Medical, AstraZeneca, Cambridge, UK
Sikhulile Moyo , Joseph Makhema
, Joseph Makhema Botswana Harvard AIDS Institute Partnership, Botswana
Harvard T.H. Chan School of Public Health, Department of Immunology and Infectious Diseases, Boston, United States
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Le texte complet de cet article est disponible en PDF.
Plan
© 2023
The British Infection Association. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 86 - N° 6
P. 603-606 - juin 2023 Retour au numéro
Article précédent
- Prevalence and risk factors of anal human papillomavirus infections among men having sex with men and transgender women in Phnom Penh, Cambodia
- Aude Jary, Sokleaph Cheng, Stéphane Marot, Gervillien Arnold Malonga, Théophile Cocherie, Steve Wignall, Vincent Calvez, Sophat Phal, Kem Vichet, Anne-Geneviève Marcelin, Gauthier Delvallez
- Discordance between semi-quantitative nucleic acid detection of bacteria and quantitative bacteriology in sputum from patients with pneumonia
- Naomi J. Gadsby, James J. Dunn, Coreen L. Johnson, Taylor McQuillan, Martin P. McHugh, Kate E. Templeton, Maria C. Rodriguez-Barradas, Daniel M. Musher
Bienvenue sur EM-consulte, la référence des professionnels de santé.